UBS Group reaffirmed their neutral rating on shares of Smith & Nephew (LON:SN) in a report issued on Monday, ThisIsMoney.Co.Uk reports.
Several other brokerages also recently weighed in on SN. Shore Capital downgraded Smith & Nephew to a sell rating in a research report on Monday, June 10th. Credit Suisse Group reaffirmed a neutral rating on shares of Smith & Nephew in a research report on Thursday, April 25th. Deutsche Bank reaffirmed a hold rating on shares of Smith & Nephew in a research report on Friday, July 12th. Berenberg Bank reaffirmed a hold rating and issued a GBX 1,475 ($19.27) target price on shares of Smith & Nephew in a research report on Friday, April 26th. Finally, JPMorgan Chase & Co. upped their target price on Smith & Nephew from GBX 1,689 ($22.07) to GBX 1,758 ($22.97) and gave the stock a neutral rating in a research report on Thursday, May 9th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and one has issued a buy rating to the company. The stock has a consensus rating of Hold and a consensus price target of GBX 1,540 ($20.12).
LON:SN traded down GBX 37.50 ($0.49) on Monday, hitting GBX 1,887 ($24.66). 1,919,808 shares of the stock were exchanged, compared to its average volume of 3,250,000. The stock has a market capitalization of $16.51 billion and a PE ratio of 24.93. The company has a debt-to-equity ratio of 30.12, a quick ratio of 1.08 and a current ratio of 2.10. The business has a fifty day moving average of GBX 1,742.23. Smith & Nephew has a fifty-two week low of GBX 1,242.50 ($16.24) and a fifty-two week high of GBX 1,802 ($23.55).
Smith & Nephew Company Profile
Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.
See Also: What is net income?
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.